Stoke Therapeutics, Inc. (NASDAQ:STOK) Receives $23.20 Average Price Target from Brokerages
Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) have earned a consensus recommendation of “Buy” from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Five investment analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 1-year […]
Shares of Stoke Therapeutics, Inc. (NASDAQ:STOK – Get Free Report) have earned a consensus recommendation of “Buy” from the seven analysts that are presently covering the stock, MarketBeat Ratings reports. Five investment analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 1-year […]
